210例绝经后2型糖尿病发生骨质疏松的相关因素

doi:10.6040/j.issn.1671-7554.0.2021.0633

摘要/Abstract

摘要： 目的探讨绝经后2型糖尿病(T2DM)女性发生骨质疏松(OP)的相关因素,并进一步分析相关因素对OP的预测价值。方法选取绝经后女性T2DM患者337例,根据骨密度结果将患者分为OP组(n=210)和正常骨量组(NBM组,n=127),记录患者的一般资料,检测糖化血红蛋白、肝功、肾功、血脂等指标,应用双能X线骨密度仪测定骨密度。采用SPSS 22.0软件对数据进行统计学分析,对两组一般资料进行比较,采用二分类Logistics回归进行多因素分析,采用Pearson相关分析对绝经时间、初潮年龄和绝经年龄与其他指标的相关性,绘制受试者工作特征曲线(ROC)并计算曲线下面积(AUC),评价多因素回归模型对绝经后T2DM女性患者发生OP诊断预测价值。结果 OP组患者的年龄(P<0.001)、糖尿病病程(P<0.001)、初潮年龄(P=0.001)以及患者绝经时间(P<0.001)均高于NBM组,而OP组患者的体质量指数(BMI)低于NBM组(P=0.006),且差异具有统计学意义。二分类Logistics回归结果显示,患者年龄(OR=1.10,95%CI=1.01~1.21,P=0.031)、绝经时间(OR=1.17,95%CI=1.07~1.28,P<0.001)、合并肾病(OR=3.52,95%CI=1.42~8.75,P=0.007)及有钙摄取(OR=11.41,95%CI=4.94~26.34,P<0.001)为患者发生OP的危险因素,而BMI(OR=0.86,95%CI=0.78~0.95,P=0.002)和有习惯性锻炼(OR=0.28,95%CI=0.13~0.60,P<0.001)为保护性因素。以这些变量构建的预测概率分值经ROC曲线分析显示,AUC为0.919,最佳诊断临界值为0.665,诊断效能敏感度为81.3%,特异度为89.8%。结论年龄大、绝经时间长、合并肾病、低BMI及缺乏习惯性锻炼为绝经后T2DM患者发生OP的危险因素。钙摄取与OP风险增加的相关性可能与有OP倾向的女性有意增加钙摄取有关。

关键词: 绝经后女性, 2型糖尿病, 骨质疏松, 预测因素, 绝经时间

Abstract: Objective To investigate the related factors of osteoporosis(OP)in postmenopausal women with type 2 diabetes mellitus(T2DM)and to analyze their predictive value. Methods A total of 337 postmenopausal women with T2DM were selected. According to the results of bone mineral density, the patients were divided into the OP group(n=210)and normal bone mass group(NBM group, n=127). The general data of the subjects were recorded, and indexes such as HbA1c, liver function, kidney function and blood lipid were detected. The bone mineral density was measured with dual-energy X-ray absorptiometry. SPSS 22.0 software was used for statistical analysis. The general data of the two groups were statistically analyzed. Logistics regression was used for multivariate analysis. Pearson correlation analysis was used to analyze the correlation among menopausal duration, age of menarche, age of menopause and other indicators. Receiver operating characteristic(ROC)curve was drawn and the area under the curve(AUC)was calculated to evaluate the value of multivariate regression model in the diagnosis and prediction of OP. Results The age(P<0.001), duration of diabetes(P<0.001), age of menarche(P=0.001)and menopausal duration(P<0.001)in the OP group were higher or longer than those in NBM group, while the body mass index(BMI)in OP group was lower than that in NBM group(P=0.006). Binary Logistic regression results showed that age(OR=1.10, 95%CI=1.01-1.21, P=0.031), menopausal duration(OR=1.17, 95%CI=1.07-1.28, P<0.001), complicated nephropathy (OR=3.52, 95%CI=1.42-8.75, P=0.007)and calcium intake(OR=11.41, 95%CI=4.94-26.34, P<0.001)were risk factors for OP, while BMI(OR=0.86, 95%CI=0.78-0.95, P=0.002)and habitual exercise(OR=0.28, 95%CI=0.13-0.60, P<0.001)were protective factors. The AUC was 0.919; the optimal diagnostic cut-off value was 0.665; the sensitivity and specificity of diagnostic efficacy were 81.3% and 89.8%, respectively. Conclusion Old age, long menopausal duration, complicated nephropathy, low BMI and lack of habitual exercise are the risk factors for OP in postmenopausal women with T2DM. The association between calcium intake and increased risk of OP may be related to the intentional increase in calcium intake.

Key words: Postmenopausal women, Type 2 diabetes mellitus, Osteoporosis, Predictive factor, Menopausal duration

中图分类号:

R587.2

吕丽,姜璐,陈诗鸿,庄向华,宋玉文,王殿辉,安文娟,李倩,潘喆. 210例绝经后2型糖尿病发生骨质疏松的相关因素[J]. 山东大学学报 (医学版), 2021, 59(7): 19-25.

LYU Li, JIANG Lu, CHEN Shihong, ZHUANG Xianghua, SONG Yuwen, WANG Dianhui, AN Wenjuan, LI Qian, PAN Zhe. Related factors of osteoporosis in 210 postmenopausal women with type 2 diabetes mellitus[J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 19-25.

参考文献

[1] Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study [J]. BMJ, 2020, 369: m997. doi: 10.1136/bmj.m997.
[2] Karimifar M, Pasha MA, Salari A, et al. Evaluation of bone loss in diabetic postmenopausal women [J]. J Res Med Sci, 2012, 17(11): 1033-1038.
[3] Shan PF, Wu XP, Zhang H, et al. Bone mineral density and its relationship with body mass index in postmenopausal women with type 2 diabetes mellitus in mainland China [J]. J Bone Miner Metab, 2009, 27(2): 190-197.
[4] Shan PF, Wu XP, Zhang H, et al.Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus [J]. J Endocrinol Invest, 2011, 34(3): 190-196.
[5] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4-67.
[6] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-443.
[7] Feng J, Liu S, Ma S, et al. Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway [J]. Acta Biochim Biophys Sin(Shanghai), 2014, 46(12): 1024-1033.
[8] Schulman RC, Weiss AJ, Mechanick JI. Nutrition, bone, and aging: an integrative physiology approach [J]. Curr Osteoporos Rep, 2011, 9(4): 184-195.
[9] Orimo H, Nakamura T, Hosoi T, et al. Japanese 2011 guidelines for prevention and treatment of osteoporosis - executive summary [J]. Arch Osteoporos, 2012, 7(1): 3-20.
[10] Marin C, Luyten FP, Van der Schueren B, et al. The Impact of Type 2 Diabetes on Bone Fracture Healing [J]. Front Endocrinol(Lausanne), 2018, 9: 6. doi: 10.3389/fendo.2018.00006.
[11] 熊雪松, 余显霞. 2型糖尿病与骨质疏松症相关性研究进展[J]. 中国骨质疏松杂志, 2017, 23(1): 130-135. XIONG Xuesong, YÜ Xianxia. The recent progress in the association between T2DM and osteoporosis [J]. Chinese Journal of Osteoporosis, 2017, 23(1): 130-135.
[12] Cavkaytar S, Seval MM, Atak Z, et al. Effect of reproductive history, lactation, first pregnancy age and dietary habits on bone mineral density in natural postmenopausal women [J]. Aging Clin Exp Res, 2015, 27(5): 689-694.
[13] Akdeniz N, Akpolat V, Kale A, et al. Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset [J]. Gynecol Endocrinol, 2009, 25(2): 125-129.
[14] Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women [J]. J Clin Endocrinol Metab, 2008, 93(3): 861-868.
[15] Walsh JS, Vilaca T. Obesity, Type 2 Diabetes and Bone in Adults [J]. Calcif Tissue Int, 2017, 100(5): 528-535.
[16] Oikawa A, Siragusa M, Quaini F, et al. Diabetes mellitus induces bone marrow microangiopathy [J]. Arterioscler Thromb Vasc Biol, 2010, 30(3): 498-508.
[17] Clausen P, Feldt-Rasmussen B, Jacobsen P, et al. Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients [J]. Diabet 1997, 14(12): 1038-1043.
[18] Yamada S, Inaba M. Diabetes mellitus and osteoporosis. Bone metabolic disorder in diabetic nephropathy [J]. Clin Calcium, 2012, 22(9): 1333-1341.
[19] Zhao X, Zhang XM, Yuan N, et al. Associations of bone mineral density and bone metabolism indices with Urine Albumin to Creatinine Ratio in Chinese Patients with Type 2 Diabetes [J]. Exp Clin Endocrinol Diabetes, 2019, 127(1): 50-55.
[20] Fang A, Li K, Guo M, et al. Long-term low intake of dietary calcium and fracture risk in older adults with plant-based diet: a longitudinal study from the China Health and Nutrition Survey [J]. J Bone Miner Res, 2016, 31(11): 2016-2023.
[21] Pluskiewicz W, Adamczyk P, Drozdzowska B. Low dietary calcium intake does not modify fracture risk but increases falls frequency: the results of GO Study [J]. Endokrynol Pol, 2021. doi: 10.5603/EP.a2021.0021.
[22] Zhao JG, Zeng XT, Wang J, et al. Association between calcium or Vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and Meta-analysis [J]. JAMA, 2017, 318(24): 2466-2482.
[23] Reid IR, Bolland MJ, Grey A. Effect of calcium supplementation on hip fractures [J]. Osteoporos Int, 2008, 19(8): 1119-1123.
[24] Griffith JF, Engelke K, Genant HK. Looking beyond bone mineral density: Imaging assessment of bone quality [J]. Ann N Y Acad Sci, 2010, 1192: 45-56. doi: 10.1111/j.1749-6632.2009.05378.x.
[25] Prentice A. Diet, nutrition and the prevention of osteoporosis [J]. Public Health Nutr, 2004, 7(1A): 227-243.

相关文章 15

[1]	邢小平. 原发性骨质疏松症诊治思考[J]. 山东大学学报 (医学版), 2021, 59(6): 1-4.
[2]	程晓光,卢艳慧. 男性骨质疏松:一个长期被忽视的问题[J]. 山东大学学报 (医学版), 2021, 59(6): 5-9.
[3]	罗湘杭,周若玙. 骨质疏松的病因及发病机制研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 10-14.
[4]	李敏启,杜娟,杨盼盼,寇雨莹,柳珊珊. 氧化应激调控骨质疏松症的研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 16-24.
[5]	陈诗鸿. 糖皮质激素性骨质疏松症研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 33-37.
[6]	郑凤杰,宋玉文,孙爱丽,潘喆,王殿辉,娄能俊,吕丽, 庄向华,陈诗鸿. 糖尿病周围神经病变与肌少症的关联性[J]. 山东大学学报 (医学版), 2021, 59(6): 38-44.
[7]	杜娇娇,庄向华,陈诗鸿,王雪萌,姜冬青,吴菲,韩晓琳,华梦羽,宋玉文. 绝经后骨质疏松症患者血清IL-31、IL-33表达变化[J]. 山东大学学报 (医学版), 2021, 59(6): 45-50.
[8]	刘萍,宋玉文,王萍,田光伟,郑凤杰,吕丽,杜娇娇,张静,庄向华,陈诗鸿. 维生素D缺乏与2型糖尿病合并抑郁状态的相关性[J]. 山东大学学报 (医学版), 2021, 59(6): 51-56.
[9]	张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[10]	苏萍,杨亚超,杨洋,季加东,阿力木·达依木,李敏,薛付忠,刘言训. 健康管理人群2型糖尿病发病风险预测模型[J]. 山东大学学报（医学版）, 2017, 55(6): 82-86.
[11]	徐大霞,侯楠,李晓峰,王闯,孔猛,焦广俊,陈允震. 糖皮质激素性骨质疏松症骨代谢与糖皮质激素用药时间的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 103-107.
[12]	李帅,王雅琳,孙忠文,朱梅佳. Nod样受体蛋白3炎性体在2型糖尿病脑微血管内皮细胞中的变化及变化机制[J]. 山东大学学报（医学版）, 2017, 55(3): 6-11.
[13]	杨洋,张光,张成琪,宋心红,薛付忠,王萍,王丽,刘言训. 基于体检队列的2型糖尿病风险预测模型[J]. 山东大学学报（医学版）, 2016, 54(9): 69-72.
[14]	彭力,强晔,赵蕙琛,陈诗鸿,姚伟东,刘元涛. 2型糖尿病患者应用西格列汀的短期疗效及影响因素[J]. 山东大学学报（医学版）, 2016, 54(8): 60-63.
[15]	林栋,管庆波. 2型糖尿病男性患者血清睾酮水平低下对非酒精性脂肪肝的影响[J]. 山东大学学报（医学版）, 2016, 54(7): 33-37.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed